Purpose of Review <p>tTo assess the evolving role of endoscopy assessment for esophageal varices in cirrhosis.</p> Recent Findings <p>The approach to screening endoscopy for varices has significantly changed in the last 10 years with the refinement of non-diagnostic tests.</p> Summary <p>Non-invasive diagnostic methods have reduced the need of upper endoscopies for variceal screening in patients with compensated cirrhosis, focusing primarily on those with ambiguous risk assessments or contraindications to non-selective beta-blockers (NSBBs). In contrast, decompensated cirrhosis patients require more frequent endoscopic evaluations due to their heightened risk of complications and the potential benefit of combination therapy (NSBBs + variceal ligation). In patients with hepatocellular carcinoma (HCC) the performance of non-invasive tests is suboptimal and most patients require endoscopy. Emerging applications of artificial intelligence (AI) can assist in patient triage and the interpretation of endoscopic findings, potentially improving care. Further research is essential to validate these technologies within clinical practice and optimize their integration into patient management strategies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Future of Endoscopy in Surveillance of Esophageal Varices

  • Carlos Moctezuma-Velazquez,
  • Juan G. Abraldes

摘要

Purpose of Review

tTo assess the evolving role of endoscopy assessment for esophageal varices in cirrhosis.

Recent Findings

The approach to screening endoscopy for varices has significantly changed in the last 10 years with the refinement of non-diagnostic tests.

Summary

Non-invasive diagnostic methods have reduced the need of upper endoscopies for variceal screening in patients with compensated cirrhosis, focusing primarily on those with ambiguous risk assessments or contraindications to non-selective beta-blockers (NSBBs). In contrast, decompensated cirrhosis patients require more frequent endoscopic evaluations due to their heightened risk of complications and the potential benefit of combination therapy (NSBBs + variceal ligation). In patients with hepatocellular carcinoma (HCC) the performance of non-invasive tests is suboptimal and most patients require endoscopy. Emerging applications of artificial intelligence (AI) can assist in patient triage and the interpretation of endoscopic findings, potentially improving care. Further research is essential to validate these technologies within clinical practice and optimize their integration into patient management strategies.